ILMN
Illumina, Inc. · Healthcare · Diagnostics & Research
TECHStrong BuyZACKSBuy
R500#39 today
$273.04
+2.75% today · +1.13% 1W
Oct 2 close or latest
PreviewWhy it's moving
Outperforming without a clear catalyst yet
- ILMN +2.75% on the last session vs SPY +0.74%: +2.0 pts of stock-specific move.
- Aftermath, rsi overbought (Oct 2): After its 11 overbought readings in the past 5 years, ILMN typically gained 3.2% over the next month (median) and was higher 64% of the time; half the outcomes fell between -1.7% and +10.8%. An ordinary month: -0.1%. Among S&P 500 stocks after overbought readings, that ranks #117 of 501.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 29
In 25 days
estimated date
EPS estimate
$1.36
$1.33 to $1.38 · 18 analysts
Revenue estimate
$1.2B
$1.1B to $1.2B
Track record
7/8 beats
last 8 reports · moved ±8.2% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 AMC | 2Q2026 | $1.23 | $1.31 | +$0.08 (+6.8%) beat | $1.2B | 0.0% -0.7 vs SPY | -0.9% | -5.5% |
| Apr 30, 2026 AMC | 1Q2026 | $1.05 | $1.15 | +$0.10 (+9.0%) beat | $1.1B | +7.1% +6.8 vs SPY | +5.1% | +9.4% |
| Feb 5, 2026 AMC | 4Q2025 | $1.23 | $1.35 | +$0.12 (+9.7%) beat | $1.2B | -10.4% -12.3 vs SPY | -5.7% | -14.3% |
| Oct 30, 2025 AMC | 3Q2025 | $1.17 | $1.34 | +$0.17 (+14.7%) beat | $1.1B | +24.8% +24.4 vs SPY | +8.0% | +22.3% |
| Jul 31, 2025 AMC | $1.01 | $1.19 | +$0.18 (+17.8%) beat | — | -7.8% -6.2 vs SPY | -9.8% | -7.0% | |
| May 8, 2025 AMC | $0.94 | $0.97 | +$0.03 (+3.2%) beat | — | -4.8% -4.7 vs SPY | -0.1% | +1.7% | |
| Feb 6, 2025 AMC | $0.92 | $0.86 | −$0.06 (−6.5%) miss | — | -9.6% -8.6 vs SPY | -9.4% | -17.1% | |
| Nov 4, 2024 AMC | $0.88 | $1.14 | +$0.26 (+29.5%) beat | — | +1.0% -0.2 vs SPY | -3.5% | -1.3% | |
| Aug 6, 2024 AMC | $0.90 | $0.36 | −$0.54 (−60.0%) miss | — | +4.1% +4.7 vs SPY | +3.0% | +2.9% | |
| May 2, 2024 AMC | $0.11 | $0.09 | −$0.02 (−18.2%) miss | — | -4.9% -6.1 vs SPY | +2.5% | -10.2% | |
| Feb 8, 2024 AMC | $0.12 | $0.14 | +$0.02 (+16.7%) beat | — | -3.8% -4.4 vs SPY | +0.3% | +1.9% | |
| Nov 9, 2023 AMC | $0.14 | $0.33 | +$0.19 (>+100%) beat | — | -8.1% -9.6 vs SPY | -12.1% | -11.0% | |
| Aug 9, 2023 AMC | $0.02 | $0.32 | +$0.30 beat | — | +0.3% +0.3 vs SPY | -3.0% | -8.1% | |
| Apr 25, 2023 AMC | $0.03 | $0.08 | +$0.05 beat | — | -3.5% -3.1 vs SPY | -1.0% | -10.8% | |
| Feb 7, 2023 AMC | $0.19 | $0.14 | −$0.05 (−26.3%) miss | — | -8.0% -6.9 vs SPY | -3.0% | -1.4% | |
| Nov 3, 2022 AMC | $0.30 | $0.34 | +$0.04 (+13.3%) beat | — | +5.9% +4.4 vs SPY | -2.5% | +13.3% | |
| Aug 11, 2022 AMC | $0.64 | $0.57 | −$0.07 (−10.9%) miss | — | -8.4% -10.1 vs SPY | -11.9% | -8.1% | |
| May 5, 2022 AMC | $0.89 | $1.07 | +$0.18 (+20.2%) beat | — | -14.6% -14.0 vs SPY | -3.0% | -25.5% | |
| Feb 10, 2022 AMC | $0.49 | $0.75 | +$0.26 (+53.1%) beat | — | -7.6% -5.6 vs SPY | -4.2% | -11.2% | |
| Nov 4, 2021 AMC | $1.22 | $1.45 | +$0.23 (+18.9%) beat | — | -3.2% -3.6 vs SPY | +0.3% | -8.7% | |
| Aug 5, 2021 AMC | $1.36 | $1.87 | +$0.51 (+37.5%) beat | — | — | — | — | |
| Apr 27, 2021 AMC | $1.40 | $1.89 | +$0.49 (+35.0%) beat | — | — | — | — | |
| Feb 11, 2021 AMC | $1.13 | $1.22 | +$0.09 (+8.0%) beat | — | — | — | — | |
| Oct 29, 2020 AMC | $0.80 | $1.02 | +$0.22 (+27.5%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $1.36 (18) | $1.33 – $1.38 | +1% | -0.9% | ▲6 ▼8 | $1.2B | +6% |
| Next quarter · Dec 31, 2026 | $1.54 (18) | $1.50 – $1.58 | +14% | +3.1% | ▲12 ▼0 | $1.2B | +5% |
| Current year · Dec 31, 2026 | $5.36 (21) | $5.32 – $5.40 | +11% | +2.4% | ▲1 ▼1 | $4.6B | +6% |
| Next year · Dec 31, 2027 | $6.11 (21) | $5.73 – $6.56 | +14% | +2.9% | ▲3 ▼1 | $4.9B | +6% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.